Translationell Neurologi

Organisation: forskargrupp


Ämnesklassifikation (UKÄ)

  • Neurologi


Our ultimate research vision is to discover, develop and implement novel neuroprotective and neurorestorative therapies for neurological disorders such as Parkinson’s disease, Huntingtons disease and stroke. My group works with translational research that is tightly linked to clinical research questions. Our experimental focus is to understand neurovascular disease mechanisms. We examine the dysfunction of the neurovascular unit, in particular pericytes, as key players in inflammation and neurodegeneration and as potential target cells for brain repair using in vitro and in vivo disease modeling and also clinical material. We work on cell target identification for brain repair, on novel restorative molecules as well as on the clinical implementation of stem cell and different growth factor therapies for Parkinson’s disease

Senaste forskningsoutput

Michaela Roth, Abderahim Gaceb, Andreas Enström, Padel, T., Genové, G., Ozen, I. & Gesine Paul-Visse, 2019 aug, I : FASEB Journal. 33, 8, s. 8990-8998 9 s.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Gesine Paul & Sullivan, A. M., 2019, I : European Journal of Neuroscience. 49, 4, s. 440-452

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Padel, T., Michaela Roth, Abderahim Gaceb, Jia Yi Li, Maria Björkqvist & Gesine Paul, 2018 jul 1, I : Experimental Neurology. 305, s. 139-150 12 s.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Visa alla (19)